This week’s update highlights four clinically relevant studies that were not central topics in the prior Belite report. The findings involve early treatment response, medication persistence, reduced-frequency maintenance dosing, bone health, and cardiovascular outcomes. Several are observational or exploratory and should not be interpreted as definitive practice-changing evidence. Rapid Early Weight Loss Did Not Appear
